Citigroup’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.2K | Sell |
15,116
-7,578
| -33% | -$10.6K | ﹤0.01% | 4329 |
|
|
2025
Q1 | $36.5K | Sell |
22,694
-2,614
| -10% | -$4.21K | ﹤0.01% | 4195 |
|
|
2024
Q4 | $31.9K | Buy |
25,308
+3,559
| +16% | +$4.48K | ﹤0.01% | 4345 |
|
|
2024
Q3 | $40.9K | Buy |
21,749
+15,152
| +230% | +$28.5K | ﹤0.01% | 4281 |
|
|
2024
Q2 | $48.8K | Buy |
6,597
+1,946
| +42% | +$14.4K | ﹤0.01% | 3865 |
|
|
2024
Q1 | $36.4K | Buy |
4,651
+725
| +18% | +$5.68K | ﹤0.01% | 4041 |
|
|
2023
Q4 | $19.9K | Buy |
3,926
+3,906
| +19,530% | +$19.8K | ﹤0.01% | 4236 |
|
|
2023
Q3 | $118 | Sell |
20
-7,726
| -100% | -$45.6K | ﹤0.01% | 4619 |
|
|
2023
Q2 | $57.5K | Sell |
7,746
-42,065
| -84% | -$312K | ﹤0.01% | 3884 |
|
|
2023
Q1 | $471K | Buy |
49,811
+659
| +1% | +$6.23K | ﹤0.01% | 2571 |
|
|
2022
Q4 | $523K | Buy |
49,152
+41,523
| +544% | +$442K | ﹤0.01% | 2499 |
|
|
2022
Q3 | $56K | Buy |
+7,629
| New | +$56K | ﹤0.01% | 3628 |
|
|
2020
Q4 | – | Sell |
-1,005
| Closed | -$10K | – | 5182 |
|
|
2020
Q3 | $10K | Buy |
+1,005
| New | +$10K | ﹤0.01% | 4292 |
|
|
2016
Q2 | – | Sell |
-4
| Closed | – | – | 4945 |
|
|
2016
Q1 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5328 |
|
|
2015
Q2 | – | Sell |
-146
| Closed | -$11K | – | 5515 |
|
|
2015
Q1 | $11K | Buy |
146
+25
| +21% | +$1.88K | ﹤0.01% | 4711 |
|
|
2014
Q4 | $21K | Buy |
121
+96
| +384% | +$16.7K | ﹤0.01% | 4564 |
|
|
2014
Q3 | $5K | Buy |
25
+19
| +317% | +$3.8K | ﹤0.01% | 4899 |
|
|
2014
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 5246 |
|